Followers | 520 |
Posts | 40228 |
Boards Moderated | 21 |
Alias Born | 09/16/2007 |
Monday, June 20, 2011 12:16:29 PM
Are you ready for the 'u'?
CLEVELAND, June 20, 2011 /PRNewswire via COMTEX/ -- DATATRAK International, Inc.
(otcqx:DATA), a technology and services company focused on global eClinical
solutions for the clinical trials industry, today announced the expansion and
rebranding of their unified software suite as DATATRAK ONE(TM). The unified
software suite consists of seven products - all of which are being demonstrated
at the 2011 DIA National Meeting.
DATATRAK ONE(TM) provides an end-to-end clinical enterprise solution by
empowering clinical users and service providers with the components necessary for
efficiently designing, delivering and managing their clinical trials. Being the
only patented, unified solution differentiates DATATRAK in a marketplace where
eClinical efficiency is compromised by integration. The DATATRAK ONE(TM) unified
product suite includes the following products, all built on a single database:
uCTMS - unified Clinical Trial Management System
uDesign - unified Trial Design
uEDC - unified Electronic Data Collection
uIRT - unified Interactive Response Technology
uSafety - unified Safety Submission
uTrain - unified Training Program
uCDR - unified Clinical Data Repository
"Because DATATRAK ONE(TM)'s products are unified and work seamlessly together,
there is no need to make complex data connections. Our unique design gives our
clients an advantage in the marketplace in terms of cost, timelines and
ease-of-use," stated Chris Wilke, DATATRAK's Chief Technology Officer. "In
providing a simple, easy-to-use product suite, the DATATRAK ONE(TM) solution
safely accelerates drug programs from concept to cure(TM)."
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering
eClinical solutions and related services for the clinical trials industry.
DATATRAK built its multi-component, comprehensive solution on a single, unified
platform and expanded this concept to include services delivery via DATATRAK's
Clinical and Consulting Services(TM) group. The Company delivers a complete
portfolio of software products designed to accelerate the reporting of clinical
research data from sites to sponsors and ultimately regulatory authorities,
faster and more efficiently than loosely integrated technologies. The DATATRAK
unified software suite, deployed worldwide through an ASP or Enterprise Transfer
offering, supports Phase I - Phase IV drug and devices studies in multiple
languages throughout the world. DATATRAK has offices located in Cleveland, Ohio;
Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit
http://www.datatrak.net.
Except for the historical information contained in this press release, the
statements made in this release are forward-looking statements. These
forward-looking statements are made based on management's expectations,
assumptions, estimates and current beliefs concerning the operations, future
results and prospects of the Company and are subject to uncertainties and factors
which are difficult to predict and, in many instances, are beyond the control of
the Company, and which could cause actual results to differ materially from those
contemplated in these forward-looking statements. For a list of certain of the
factors that may cause actual results to differ materially from those
contemplated in these forward looking statements, please see the Company's
quarterly report filed with the OTCQX Market announcing its results for the
three-month period ending March 31, 2011. The Company undertakes no obligation to
update publicly or revise any forward-looking statement whether as a result of
new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
Copyright (C) 2011 PR Newswire. All rights reserved
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM